SEMEY MEDICAL UNIVERSITY

(Nauka i Zdravookhranenie)

Peer-reviewed scientific medical journal

Science & Healthcare

Advanced Search

DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN

Authors

  • Lyudmila Karazhanova Автор

DOI:

https://doi.org/10.34689/8d8y0140

Keywords:

arterial hypertension , calcium channel blockers , Lerkamen

Abstract

Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF) and hypertensive nephropathy, death from cardiovascular diseases. Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality. This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.

Author Biography

  • Lyudmila Karazhanova

    Государственный медицинский университет города Семей

References

Л.К. Каражанова АНТАГОНИСТЫ КАЛЬЦИЯ ДИГИДРОПИРИДИНОВОГО РЯДА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ: В ФОКУСЕ ЛЕРКАМЕН //НАУКА И ЗДРАВООХРАНЕНИЕ 2012.№ 2. С. 18-24 L.K. Karazhanova DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN // NAUKA I RAVOOKHRANENIE. 2012.№ 2. С. 18-24 Л.Қ. Қаражанова АРТЕРИАЛДЫ ГИПЕРТОНИЯНЫҢ ЕМІНДЕ ДИГИДРОПИРИДИН ТУЫНДЫСЫ КАЛЬЦИЙ АНТАГОНИСТЕРІ: ФОКУСТА ЛЕРКАМЕН // ҒЫЛЫМ ЖӘНЕ ДЕНСАУЛЫҚ САҚТАУ. 2012.№ 2. С. 18-24

Downloads

Published

2026-02-26

Issue

Section

Статьи

Categories

How to Cite

DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN. (2026). Рецензируемый медицинский научно-практический журнал «Наука и здравоохранение», 14(2), 18-24. https://doi.org/10.34689/8d8y0140

Most read articles by the same author(s)

1 2 3 > >> 

Similar Articles

You may also start an advanced similarity search for this article.